Bioprocessing
AGC Biologics, AdaptVac partner on COVID-19 vaccine
AGC Biologics, a contract development and manufacturing organization, and AdaptVac have teamed up to develop a COVID-19 vaccine.
COVID-19 vaccine candidates show progress amid challenges
As the COVID-19 outbreak advances worldwide, companies are stepping up to the challenge to develop a potential vaccine. There are over 75 confirmed COVID-19 vaccine candidates, five of which have already entered clinical trials.  Discuss
Fujifilm Diosynth partners with Oxgene for gene therapy
Fujifilm Diosynth Biotechnologies has partnered with Oxgene to deliver gene therapy products with a 25% reduction in production time, the company reported on April 23.
NIAID announces new COVID-19 priorities
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) has released a new strategic plan for accelerating research to diagnose, prevent, and treat COVID-19.
MilliporeSigma expands viral and gene therapy capacity
MilliporeSigma is expanding its BioReliance viral and gene therapy service offering with a second commercial manufacturing facility in Carlsbad, CA. The $110 million facility is set to open in 2021.
New COVID-19 R&D initiatives announced
A series of new initiatives aims to simplify scientific literature discovery and acquisition during the COVID-19 crisis, according to Research Solutions. These products include the launch of the COVID-19 Research Viewer Gadget.
Directed evolution shows promise in reducing drug discovery times
A research collaboration between scientists at the University of Leeds and AstraZeneca resulted in the development of a technique that can significantly reduce the discovery time for possible new antibody-based therapies. The approach, published in Nature Communications on April 14, shows how protein fragments can be screened for susceptibility to aggregation in early drug discovery.  Discuss
MilliporeSigma, Jenner Institute partner on COVID-19 vaccine
MilliporeSigma and the Jenner Institute have announced that they are preparing for large-scale manufacturing of the COVID-19 vaccine candidate ChAdOx1 nCoV-19.
Ori Biotech, Achilles to test manufacturing processes
Cell and gene therapy manufacturing firm Ori Biotech has partnered with biopharmaceutical company Achilles Therapeutics to test Ori's manufacturing technology in Achilles' manufacturing process.
ReForm gets patents for therapeutic protein formulations
ReForm Biologics has received a U.S. patent for therapeutic protein formulations that reduce protein aggregation and stabilize proteins during storage.
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter